« Success Achieved Through Two different Stem cell Treatment Procedure for Spinal Cord Injury Patients
Students Rally to Create Awareness on Diabetes on the Occasion of World Diabetes Day »

Allergan’s Intraocular Pressure Drug Lumigan Received FDA Approval

The FDA has approved Allergan's once-daily prescription eye drop Lumigan as a first-line treatment for elevated intraocular pressure associated with open-angle glaucoma or ocular hypertension. The Lumigan first-line indication is in addition to the product's already established use as a second-line treatment, for which the FDA approved the drug in 2001. Read the full article here.

Filed under Eye Treatment, Glaucoma

You may also like to read

This entry was posted on Thursday, June 29th, 2006 at 8:21 am and is filed under Eye Treatment, Glaucoma. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply



Please enter the code shown below ( to verify that you are human ) before you click Submit Comment.